Thio Chemical Market is Expected to Reach USD 4,039.3 Million by 2035, Growing at 5.1% CAGR | Fact.MR Report
Growing Demand for Thio Chemicals Across Various Industries is Driving the MarketRockville, MD , March 05, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence ...
Cure Today1mon
THIO and Libtayo Extends OS in NSCLC Following Progression on SOC Therapy
THIO, a first-in-class agent, targets telomeres, inducing cancer cell death and activating immune responses in NSCLC. The THIO-101 trial showed a median overall survival of 16.9 months, surpassing ...
Hosted on MSN1mon
MAIA Biotechnology announces updated data from THIO-101 trial
MAIA Biotechnology (MAIA) announced updated data from its THIO-101 pivotal Phase 2 clinical trial evaluating its lead clinical candidate, THIO, sequenced with Regeneron’s (REGN) immune ...
MAIA Biotech announces trial design to expand THIO-101 Phase 2 NSCLC study
MAIA Biotechnology (MAIA) announced the trial design for the expansion of its THIO-101 pivotal Phase 2 trial in non-small cell lung cancer ...
MAIA Biotechnology to initiate THIO-104 trial
MAIA Biotechnology (MAIA) announced plans to initiate a Phase 3 pivotal trial in 2025, named THIO-104, to evaluate the efficacy of THIO ...
Yahoo Finance15d
MAIA Biotechnology Announces Design for Expansion of THIO-101 Phase 2 Trial in Advanced Non-Small Cell Lung Cancer
Following successful outcomes to date in THIO-101, the expansion of the study will assess overall response rates (ORR) in advanced NSCLC patients receiving third line (3L) therapy who were ...
The Business Times3d
Singapore Global Trust edge out Team Boss on countback for first-round honours
SINGAPORE] The first leg of this year’s The Business Times Corporate Golf League is over, and already things are looking ...